Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) has appointed former OMERS venture capitalist and Canopy Rivers President, Mr. Narbé Alexandrian, to Chief Executive Officer of the company, effective immediately. Canopy Rivers’ former CEO, Bruce Linton, will continue to serve as Chairman of the Canopy Rivers Board of Directors. “I would like to thank Bruce, the Board … Continue reading “CBDNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Names New Chief Executive Officer; Hosting Analyst and Investor Day May 28”
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced that its portfolio company, Agripharm Corp., has received its outdoor cultivation license from Health Canada. According to the update, Agripharm will use award-winning genetics to grow its first outdoor crop this summer at its Creemore, Ontario location. “We are pleased to see Agripharm diversify its operations and … Continue reading “CBDNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Agripharm Corp. Awarded Outdoor Cultivation License”
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced a strategic investment in BioLumic Ltd., creators of a sustainable ultraviolet (“UV”) crop yield enhancement system. Canopy Rivers’ investment of $1.5 million marked its first investment in agri-technologies, specifically focused on the promising fields of plant physiology and UV photobiology. “Canopy Rivers’ mission is to build and … Continue reading “CBDNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Makes Strategic and First AgTech Investment in BioLumic”
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced that its 49 percent-owned portfolio company, PharmHouse Inc., has entered into a second offtake agreement with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. According to the update, the agreement commits an additional … Continue reading “CBDNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) PharmHouse Enters Significant Supply, Offtake Agreement with Canopy Growth Corp. (TSX: WEED) (NYSE: CGC)”
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has been issued a Good Manufacturing Practice (“GMP”) certificate in accordance with the rules governing medicinal products in the European Union (“EU”) for its Mississauga, Ontario, Canada facility. According to the update, TerrAscend has also entered into … Continue reading “CBDNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Receives EU GMP Certification, Enters Comprehensive Distribution Agreement”
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced the completion of an investment in High Beauty, the creator of the cannabis beauty brand high. According to the update, the company has subscribed for $2.5 million of shares representing 18.4% of High Beauty on a fully diluted basis, including additional warrant coverage. “We have been … Continue reading “CBDNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Invests in High Beauty”
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, James E. Wagner Cultivation Corporation (“JWC”) (TSX.V: JWCA) (OTCQX: JWCAF), has received a cultivation license from Health Canada for its Kitchener-based commercial-scale production facility (“JWC2”). Per the update, reception of this license will result in the launch of the initial phase … Continue reading “CBDNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Receives Second Site License from Health Canada”
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced receipt of a Health Canada cultivation license for Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its portfolio company, Spot Therapeutics Inc., for its Fredericton-based production and distribution facility. Per the update, the newly licensed facility will operate under the flagship Tweed banner, and the cultivation license … Continue reading “CBDNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Spot Therapeutics Receives Health Canada Cultivation License, Triggering Long-Term Cash Flow”
Cannabis-focused investment and operating platform Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF), alongside LeafLink Inc., this morning announced the establishment of LeafLink Services International ULC, a new venture focused on licensing and leveraging LeafLink’s dominant business-to-business marketplace and supply chain technology platform for deployment through regulated international cannabis markets. “We have been very impressed with … Continue reading “CBDNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces New Joint Venture with LeafLink Inc.”
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) on Thursday announced that its portfolio company, Headset, Inc., formed a landmark strategic alliance with Nielsen Holdings plc (NYSE: NLSN). According to the update, the partnership combines Nielsen’s consumer research capabilities with Headset’s real-time retail point-of-sale platform to provide U.S. cannabis market data and analytics to consumer packaged … Continue reading “CBDNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Headset Forms Strategic Alliance with Nielsen Holdings plc (NYSE: NLSN) to Provide U.S. Cannabis Market Data, Analytics to CPG Companies”
